These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Alterations in electrochemical skin conductance as a marker of autonomic dysfunction in multiple system atrophy. Georges C; Lloret-Perez S; Ory-Magne F; Fabbri M; Foubert-Samier A; Meissner WG; Rascol O; Pavy-Le Traon A Parkinsonism Relat Disord; 2022 Oct; 103():56-59. PubMed ID: 36063705 [TBL] [Abstract][Full Text] [Related]
5. Impact of depressive symptoms on self-perceived severity of autonomic dysfunction in multiple system atrophy: relevance for patient-reported outcomes in clinical trials. Martinez J; Palma JA; Norcliffe-Kaufmann L; Garakani A; Kaufmann H Clin Auton Res; 2020 Jun; 30(3):215-221. PubMed ID: 32246226 [TBL] [Abstract][Full Text] [Related]
6. Orthostatic Hypotension in Multiple System Atrophy: Related Factors and Disease Prognosis. Jiang Q; Zhang L; Lin J; Wei Q; Li C; Hou Y; Ou R; Liu K; Yang T; Xiao Y; Zhao B; Wu Y; Shang H J Parkinsons Dis; 2023; 13(8):1313-1320. PubMed ID: 38143372 [TBL] [Abstract][Full Text] [Related]
7. L-threo-dihydroxyphenylserine (L-threo-DOPS; droxidopa) in the management of neurogenic orthostatic hypotension: a multi-national, multi-center, dose-ranging study in multiple system atrophy and pure autonomic failure. Mathias CJ; Senard JM; Braune S; Watson L; Aragishi A; Keeling JE; Taylor MD Clin Auton Res; 2001 Aug; 11(4):235-42. PubMed ID: 11710796 [TBL] [Abstract][Full Text] [Related]
8. Cardiovascular autonomic testing in the work-up of cerebellar ataxia: insight from an observational single center study. Indelicato E; Fanciulli A; Nachbauer W; Eigentler A; Amprosi M; Ndayisaba JP; Granata R; Wenning G; Boesch S J Neurol; 2020 Apr; 267(4):1097-1102. PubMed ID: 31893293 [TBL] [Abstract][Full Text] [Related]
9. Association of orthostatic blood pressure with the symptoms of orthostatic hypotension and cognitive impairment in patients with multiple system atrophy. Ueda M; Nakamura T; Suzuki M; Imai E; Harada Y; Hara K; Hirayama M; Katsuno M J Clin Neurosci; 2020 May; 75():40-44. PubMed ID: 32234335 [TBL] [Abstract][Full Text] [Related]
10. Natural history of multiple system atrophy in the USA: a prospective cohort study. Low PA; Reich SG; Jankovic J; Shults CW; Stern MB; Novak P; Tanner CM; Gilman S; Marshall FJ; Wooten F; Racette B; Chelimsky T; Singer W; Sletten DM; Sandroni P; Mandrekar J Lancet Neurol; 2015 Jul; 14(7):710-9. PubMed ID: 26025783 [TBL] [Abstract][Full Text] [Related]
11. Disease progression and prognostic factors in multiple system atrophy: A prospective cohort study. Foubert-Samier A; Pavy-Le Traon A; Guillet F; Le-Goff M; Helmer C; Tison F; Rascol O; Proust-Lima C; Meissner WG Neurobiol Dis; 2020 Jun; 139():104813. PubMed ID: 32087288 [TBL] [Abstract][Full Text] [Related]
12. Impaired peripheral vasoconstrictor response to orthostatic stress in patients with multiple system atrophy. Suzuki J; Nakamura T; Hirayama M; Mizutani Y; Okada A; Ito M; Watanabe H; Sobue G Parkinsonism Relat Disord; 2015 Aug; 21(8):917-22. PubMed ID: 26054882 [TBL] [Abstract][Full Text] [Related]
13. The circulating level of leptin and blood pressure in patients with multiple system atrophy. Ozawa T; Tokunaga J; Arakawa M; Ishikawa A; Takeuchi R; Yokoseki A; Sone H; Nishizawa M J Neurol Sci; 2014 Dec; 347(1-2):349-51. PubMed ID: 25304054 [TBL] [Abstract][Full Text] [Related]
14. Ambulatory blood pressure monitoring and cardiovascular function tests in multiple system atrophy. Frongillo D; Stocchi F; Buccolini P; Stecconi P; Viselli F; Ruggieri S; Cannata D Fundam Clin Pharmacol; 1995; 9(2):187-96. PubMed ID: 7628833 [TBL] [Abstract][Full Text] [Related]
15. Symptoms associated with orthostatic hypotension in pure autonomic failure and multiple system atrophy. Mathias CJ; Mallipeddi R; Bleasdale-Barr K J Neurol; 1999 Oct; 246(10):893-8. PubMed ID: 10552235 [TBL] [Abstract][Full Text] [Related]
16. Loss of nocturnal blood pressure fall in various extrapyramidal syndromes. Schmidt C; Berg D; ; Prieur S; Junghanns S; Schweitzer K; Globas C; Schöls L; Reichmann H; Ziemssen T Mov Disord; 2009 Oct; 24(14):2136-42. PubMed ID: 19768815 [TBL] [Abstract][Full Text] [Related]
18. Assessment of the Scopa-Aut questionnaire in multiple system atrophy: relation to UMSARS scores and progression over time. Damon-Perrière N; Foubert-Samier A; De Cock VC; Gerdelat-Mas A; Debs R; Pavy-Le Traon A; Senard JM; Rascol O; Tison F; Meissner WG Parkinsonism Relat Disord; 2012 Jun; 18(5):612-5. PubMed ID: 22236582 [TBL] [Abstract][Full Text] [Related]
19. The symptomatic treatment of multiple system atrophy. Colosimo C; Pezzella FR Eur J Neurol; 2002 May; 9(3):195-9. PubMed ID: 11985626 [TBL] [Abstract][Full Text] [Related]
20. Serum lipid levels are associated with orthostatic hypotension in multiple system atrophy patients. Shi Z; Zhang J; Wang P; Han J; Li X; Liu S; Zhu H; Ji Y Parkinsonism Relat Disord; 2023 Sep; 114():105803. PubMed ID: 37567063 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]